Aptimmune Biologics, Inc. — Form D
Aptimmune Biologics, Inc. of CHAMPAIGN, IL, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-11. The offering totals $7.0M, of which $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-11
- Form: D
- Accession: 0001648213-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.2M
- Remaining: $4.8M
- Minimum investment: $80K
- Investors: 3
- Date of first sale: 2017-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-290386
Issuer
- Name: Aptimmune Biologics, Inc.
- CIK: 0001648213
- Entity type: Corporation
- Jurisdiction: ILLINOIS
- Address: 60 HAZELWOOD DRIVE, CHAMPAIGN, IL, 61820
- Phone: 217-377-8866
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Gary Durack | Director | Champaign, IL |
| Robert Easter | Director | Champaign, IL |
| Aaron Gilbertie | Director | West Lafayette, IN |
| Paul Olivo | Director | Champaign, IL |
| Federico Zuckermann | Director | Champaign, IL |
| Aaron Gilbertie | Executive Officer | West Lafayette, IN |
| Federico Zuckermann | Executive Officer | Champaign, IL |
Other filings by this issuer (2)
More